Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 23,383 | 52 | -3,828 | -10,707 | 12,672 |
| Depreciation Amortization | -4,709 | -3,377 | -2,038 | -949 | 565 |
| Accounts receivable | -78,092 | -64,634 | -32,515 | -13,889 | -51,093 |
| Other Working Capital | -109,297 | -48,557 | -16,732 | -6,067 | -84,659 |
| Other Operating Activity | 128,198 | 101,640 | 52,442 | 23,405 | 91,102 |
| Operating Cash Flow | $-40,517 | $-14,876 | $-2,671 | $-8,207 | $-31,413 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 384 | -15,425 | 143,775 | -8,130 | -50,651 |
| PPE Investments | -45 | -24 | N/A | N/A | N/A |
| Purchase Of Investment | -1,375 | -1,375 | -151,265 | -1,125 | N/A |
| Investing Cash Flow | $-1,036 | $-16,824 | $-7,490 | $-9,255 | $-50,651 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 244,815 | 244,815 | N/A | N/A | 25,000 |
| Debt Repayment | -107,553 | -107,553 | N/A | N/A | N/A |
| Common Stock Issued | 914 | 344 | 145 | 10 | 47,830 |
| Common Stock Repurchased | -8,760 | -2,149 | N/A | N/A | N/A |
| Other Financing Activity | -889 | -858 | 0 | 0 | -125 |
| Financing Cash Flow | $128,527 | $134,599 | $145 | $10 | $72,705 |
| Beginning Cash Position | 94,218 | 94,218 | 94,218 | 94,218 | 103,577 |
| End Cash Position | 181,192 | 197,117 | 84,202 | 76,766 | 94,218 |
| Net Cash Flow | $86,974 | $102,899 | $-10,016 | $-17,452 | $-9,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,517 | -14,876 | -2,671 | -8,207 | -31,413 |
| Capital Expenditure | -45 | -24 | N/A | N/A | N/A |
| Free Cash Flow | -40,562 | -14,900 | -2,671 | -8,207 | -31,413 |